National Institute for Health and Care Excellence: Medical Treatments

Department of Health and Social Care written question – answered on 14th September 2020.

Alert me about debates like this

Photo of Bambos Charalambous Bambos Charalambous Opposition Whip (Commons), Shadow Minister (Home Office)

To ask the Secretary of State for Health and Social Care, when NICE plans to publish a timetable for technology appraisals delayed as a result of the covid-19 outbreak; and whether NICE plans to prioritise the appraisals of advanced therapy medicinal products.

Photo of Helen Whately Helen Whately Minister of State (Department of Health and Social Care)

In response to the COVID-19 pandemic, the National Institute for Health and Care Excellence (NICE) paused the publication of topics that were not COVID-19 related or therapeutically critical to avoid distracting the National Health Service at a time of unprecedented pressure.

NICE has been working to reschedule multiple appraisals back into its work programme, to recover as quickly as feasibly possible. Information regarding the current timeline for each appraisal topic is published on the individual topic webpage on the NICE website.

NICE is committed to publishing final guidance for new products, including advanced therapy medicinal products within 90 days of the product first being licensed within the United Kingdom.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.